Crossref
Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease
Evidence-based Healthcare · 2003
DOI: 10.1016/j.ehbc.2003.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Evidence-based Healthcare, 2003. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2003). Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease. Evidence-based Healthcare. https://doi.org/10.1016/j.ehbc.2003.08.001
Vancouver
Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease. Evidence-based Healthcare. 2003. doi:10.1016/j.ehbc.2003.08.001
BibTeX
@article{euvimed2003,
title = {Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease},
journal = {Evidence-based Healthcare},
year = {2003},
doi = {10.1016/j.ehbc.2003.08.001}
}
EUVIMED